Literature DB >> 24373920

Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.

Riccardo Di Fiore1, Michela Marcatti1, Rosa Drago-Ferrante1, Antonella D'Anneo1, Michela Giuliano1, Daniela Carlisi2, Anna De Blasio1, Francesca Querques3, Lucio Pastore3, Giovanni Tesoriere4, Renza Vento5.   

Abstract

Osteosarcoma is a highly metastatic tumor affecting adolescents, for which there is no second-line chemotherapy. As suggested for most tumors, its capability to overgrow is probably driven by cancer stem cells (CSCs), and finding new targets to kill CSCs may be critical for improving patient survival. TP53 is the most frequently mutated tumor suppressor gene in cancers and mutant p53 protein (mutp53) can acquire gain of function (GOF) strongly contributing to malignancy. Studies thus far have not shown p53-GOF in osteosarcoma. Here, we investigated TP53 gene status/role in 3AB-OS cells-a highly aggressive CSC line previously selected from human osteosarcoma MG63 cells-to evaluate its involvement in promoting proliferation, invasiveness, resistance to apoptosis and stemness. By RT-PCR, methylation-specific PCR, fluorescent in situ hybridization, DNA sequence, western blot and immunofluorescence analyses, we have shown that-in comparison with parental MG63 cells where TP53 gene is hypermethylated, rearranged and in single copy-in 3AB-OS cells, TP53 is unmethylated, rearranged and in multiple copies, and mutp53 (p53-R248W/P72R) is post-translationally modified and with nuclear localization. p53-R248W/P72R-knockdown by short-interfering RNA reduced the growth and replication rate of 3AB-OS cells, markedly increasing cell cycle inhibitor levels and sensitized 3AB-OS cells to TRAIL-induced apoptosis by DR5 up-regulation; moreover, it strongly decreased the levels of stemness and invasiveness genes. We have also found that the ectopic expression of p53-R248W/P72R in MG63 cells promoted cancer stem-like features, as high proliferation rate, sphere formation, clonogenic growth, high migration and invasive ability; furthermore, it strongly increased the levels of stemness proteins. Overall, the findings suggest the involvement of p53-R248W/P72R at the origin of the aberrant characters of the 3AB-OS cells with the hypothesis that its GOF can be at the root of the dedifferentiation of MG63 cells into CSCs.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3AB-OS cells; Cancer cell dedifferentiation; Cancer stem cells; Human osteosarcoma; Mutant p53 gain of function

Mesh:

Substances:

Year:  2013        PMID: 24373920     DOI: 10.1016/j.bone.2013.12.021

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  15 in total

Review 1.  Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.

Authors:  Yoav Shetzer; Alina Molchadsky; Varda Rotter
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

2.  Curcumin induces apoptosis in p53-null Hep3B cells through a TAp73/DNp73-dependent pathway.

Authors:  Jinhong Wang; Hai Xie; Feng Gao; Tingkun Zhao; Hongming Yang; Bai Kang
Journal:  Tumour Biol       Date:  2015-10-22

3.  TP53 Mutations and Survival in Osteosarcoma Patients: A Meta-Analysis of Published Data.

Authors:  Zhe Chen; Jiayi Guo; Kun Zhang; Yanxing Guo
Journal:  Dis Markers       Date:  2016-04-27       Impact factor: 3.434

Review 4.  The Role of HPV in Head and Neck Cancer Stem Cell Formation and Tumorigenesis.

Authors:  Mark S Swanson; Niels Kokot; Uttam K Sinha
Journal:  Cancers (Basel)       Date:  2016-02-19       Impact factor: 6.639

5.  Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.

Authors:  Rosa Drago-Ferrante; Francesca Pentimalli; Daniela Carlisi; Anna De Blasio; Christian Saliba; Shawn Baldacchino; James Degaetano; Joseph Debono; Gordon Caruana-Dingli; Godfrey Grech; Christian Scerri; Giovanni Tesoriere; Antonio Giordano; Renza Vento; Riccardo Di Fiore
Journal:  Oncotarget       Date:  2017-04-25

6.  MicroRNA-29b-1 impairs in vitro cell proliferation, self‑renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells.

Authors:  Riccardo Di Fiore; Rosa Drago-Ferrante; Francesca Pentimalli; Domenico Di Marzo; Iris Maria Forte; Antonella D'Anneo; Daniela Carlisi; Anna De Blasio; Michela Giuliano; Giovanni Tesoriere; Antonio Giordano; Renza Vento
Journal:  Int J Oncol       Date:  2014-08-22       Impact factor: 5.650

Review 7.  Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell Targeting.

Authors:  Bing Lu; Xiaojia Huang; Jingxin Mo; Wei Zhao
Journal:  Front Pharmacol       Date:  2016-04-12       Impact factor: 5.810

8.  Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis.

Authors:  D Carlisi; G Buttitta; R Di Fiore; C Scerri; R Drago-Ferrante; R Vento; G Tesoriere
Journal:  Cell Death Dis       Date:  2016-04-14       Impact factor: 8.469

Review 9.  3D modeling of cancer stem cell niche.

Authors:  Jun He; Li Xiong; Qinglong Li; Liangwu Lin; Xiongying Miao; Shichao Yan; Zhangyong Hong; Leping Yang; Yu Wen; Xiyun Deng
Journal:  Oncotarget       Date:  2017-08-03

10.  Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.

Authors:  Salman B Hosain; Sachin K Khiste; Mohammad B Uddin; Vindya Vorubindi; Catherine Ingram; Sifang Zhang; Ronald A Hill; Xin Gu; Yong-Yu Liu
Journal:  Oncotarget       Date:  2016-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.